Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression
  2. Rasmussen, S A; Lewis, J S; Mirabello, L; Bass, S; Yeager,Meredith; Corsten, M J; Bullock, M J
  3. Head and Neck Pathology. 2022, Jun 30;
  1. 2.   Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
  2. Coyne, Geraldine O 'Sullivan; Wang,Lihua; Zlott, Jennifer; Juwara,Lamin; Covey, Joseph M; Beumer, Jan H; Cristea, Mihaela C; Newman, Edward M; Koehler, Stephen; Nieva, Jorge J; Garcia, Agustin A; Gandara, David R; Miller,Brandon; Khin,Sonny; Miller, Sarah B; Steinberg, Seth M; Rubinstein, Larry; Parchment,Ralph; Kinders,Robert; Piekarz, Richard L; Kummar, Shivaani; Chen, Alice P; Doroshow, James H
  3. Cancer chemotherapy and pharmacology. 2020, Apr 20;
  1. 3.   ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
  2. Ha, L.; Ichikawa, T.; Anver, M.; Dickins, R.; Lowe, S.; Sharpless, N. E.; Krimpenfort, P.; DePinho, R. A.; Bennett, D. C.; Sviderskaya, E. V.; Merlino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jun; 104(26): 10968-10973.
  1. 4.   Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line
  2. Song, X.; Tao, Y. G.; Zeng, L.; Deng, X. Y.; Lee, L. M.; Gong, J. P.; Wu, Q.; Cao, Y.
  3. Virus Research. 2005, NOV; 113(2): 89-99.
  1. 5.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
  1. 6.   The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity
  2. Kaldis, P.
  3. Journal of Biological Chemistry. 2005, MAR 25; 280(12): 11165-11174.
  1. 7.   Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp
  2. Mori, T.; O'Keefe, B. R.; Sowder, R. C.; Bringans, S.; Gardella, R.; Berg, S.; Cochran, P.; Turpin, J. A.; Buckheit, R. W.; McMahon, J. B.; Boyd, M. R.
  3. Journal of Biological Chemistry. 2005, MAR 11; 280(10): 9345-9353.
  1. 8.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 9.   Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells
  2. Cheng, J. C.; Weisenberger, D. J.; Gonzales, F. A.; Liang, G. N.; Xu, G. L.; Hu, Y. G.; Marquez, V. E.; Jones, P. A.
  3. Molecular and Cellular Biology. 2004 24(3): 1270-1278.
  1. 10.   Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
  2. Gloster, S. E.; Newton, P.; Cornforth, D.; Lifson, J. D.; Williams, I.; Shaw, G. M.; Borrow, P.
  3. Aids. 2004 18(5): 749-755.
  1. 11.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 12.   Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)- defficient mice
  2. Wolff, L.; Garin, M. T.; Koller, R.; Bies, J.; Liao, W.; Malumbres, M.; Tessarollo, L.; Powell, D.; Perella, C.
  3. Oncogene. 2003 22(58): 9265-9274.
  1. 13.   Oligomeric structure of the human immunodeficiency virus type I envelope protein on the virion surface
  2. Center, R. J.; Leapman, R. D.; Lebowitz, J.; Arthur, L. O.; Earl, P. L.; Moss, B.
  3. Journal of Virology. 2002 76(15): 7863-7867.
  1. 14.   INK4a-deficient human diploid fibroblasts are resistant to RAS- induced senescence
  2. Brookes, S.; Rowe, J.; Ruas, M.; Llanos, S.; Clark, P. A.; Lomax, M.; James, M. C.; Vatcheva, R.; Bates, S.; Vousden, K. H.; Parry, D.; Gruis, N.; Smit, N.; Bergman, W.; Peters, G.
  3. Embo Journal. 2002 21(12): 2936-2945.
  1. 15.   Rarity of CDK4 germline mutations in familial melanoma
  2. Goldstein, A. M.; Chidambaram, A.; Halpern, A.; Holly, E. A.; Guerry, D.; Sagebiel, R.; Elder, D. E.; Tucker, M. A.
  3. Melanoma Research. 2002 12(1): 51-55.
  1. 16.   Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways
  2. Weber, H. O.; Samuel, T.; Rauch, P.; Funk, J. O.
  3. Oncogene. 2002 21(20): 3207-3212.
  1. 17.   Adaptation of chimeric retroviruses in vitro and in vivo: Isolation of avian retroviral vectors with extended host range
  2. Barsov, E. V.; Payne, W. S.; Hughes, S. H.
  3. Journal of Virology. 2001 75(11): 4973-4983.
  1. 18.   Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors
  2. Crotty, S.; Miller, C. J.; Lohman, B. L.; Neagu, M. R.; Compton, L.; Lu, D.; Lu, F. X. S.; Fritts, L.; Lifson, J. D.; Andino, R.
  3. Journal of Virology. 2001 75(16): 7435-7452.
  1. 19.   Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation
  2. Fang, J. Y.; Mikovits, J. A.; Bagni, R.; Petrow-Sadowski, C. L.; Ruscetti, F. W.
  3. Journal of Virology. 2001 75(20): 9753-9761.
  1. 20.   Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations
  2. Goldstein, A. M.; Struewing, J. P.; Chidambaram, A.; Fraser, M. C.; Tucker, M. A.
  3. Journal of the National Cancer Institute. 2000 92(12): 1006-1010.
  1. 21.   A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONEI using a monochromosome transfer approach
  2. Cheng, Y.; Stanbridge, E. J.; Kong, H.; Bengtsson, U.; Lerman, M. I.; Lung, M. L.
  3. Genes Chromosomes & Cancer. 2000 28(1): 82-91.
  1. 22.   Alteration of p16 and p15 genes in human uterine tumours
  2. Nakashima, R.; Fujita, M.; Enomoto, T.; Haba, T.; Yoshino, K.; Wada, H.; Kurachi, H.; Sasaki, N.; Wakasa, K.; Inoue, M.; Buzard, G.; Murata, Y.
  3. British Journal of Cancer. 1999 80(3-4): 458-467.
  1. 23.   Protection from pathogenic SIV challenge using multigenic DNA vaccines
  2. Haigwood, N. L.; Pierce, C. C.; Robertson, M. N.; Watson, A. J.; Montefiori, D. C.; Rabin, M.; Lynch, J. B.; Kuller, L.; Thompson, J.; Morton, W. R.; Benveniste, R. E.; Hu, S. L.; Greenberg, P.; Mossman, S. P.
  3. Immunology Letters. 1999 66(1-3): 183-188.
  1. 24.   Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
  2. Sei, S.; Sandelli, S. L.; Theofan, G.; Ratto-Kim, S.; Kumagai, M.; Loomis-Price, L. D.; Cox, J. H.; Jarosinski, P.; Walsek, C. M.; Brouwers, P.; Venzon, D. J.; Xu, J.; Pizzo, P. A.; Moss, R. B.; Robb, M. L.; Wood, L. V.
  3. Journal of Infectious Diseases. 1999 180(3): 626-640.
  1. 25.   P16/Cdkn2 Alterations and Prb Expression in Oesophageal Squamous Carcinoma
  2. Busatto, G.; Shiao, Y. H.; Parenti, A. R.; Baffa, R.; Ruol, A.; Plebani, M.; Rugge, M.
  3. Molecular Pathology. 1998 51(2): 80-84.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel